| Application no. and date | 16725997.7 (espacenet) (Federated) (European Patent Register), 20160518 | | Patent/reg. no. and date | DK/EP 3298021, 20190501 | | Publication date | 20180328 | | Priority no. and date | US 201562163188 P, 20150518 | | EP pub. no. and date |
EP 3298021 20180328 | | Effective date | | | Applicant/owner | Sumitomo Pharma Oncology, Inc., 84 Waterford Drive
Marlborough, Massachusetts 01752
US
, US | | Applicant ref. no. | P69149DK01 | | Inventor | BEARSS, David, J., 1287 E. Chapman Court
Alpine, Utah 84004, US,
SIDDIQUI-JAIN, Adam, 11643 South Jordan Farms Road
South Jordan, Utah 84095, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/661 (2006.01) , A61P 35/00 (2006.01) , C07F 9/12 (2006.01) | | Title | ALVOCIDIB-PRODRUGS, DER HAR ØGET BIOTILGÆNGELIGHED | | Int. application no. | US2016033099 | | Int. publication no. | WO2016187316 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
